Skip to main content
Premium Trial:

Request an Annual Quote

Saeid Akhtari, Andrew Conway, Kary Mullis

Premium

Silicon Genetics has promoted COO Saeid Akhtari to president and CEO, the company said Jan. 30. Akhtari succeeds Andrew Conway, who will continue as executive chairman of the board of directors while “evaluating new technologies” for the company, according to Silicon Genetics.

Before joining Redwood City, Calif.-based Silicon Genetics in 2001, Akhtari held senior-management positions at DoubleTwist, IntelliGenetics, Pharsight, and Oxford Molecular Group.


OpGen has appointed Kary Mullis to its scientific advisory board. Mullis, a Nobel Laureate in chemistry and the inventor of PCR technology, will help OpGen develop single DNA-molecule optical-mapping technology for whole-genome analysis.

“I see great potential” in this technology “and I want to help make this technology successful in the marketplace” said Mullis. “I see this technology advancing the genomics field much like PCR did in the late ‘80s.”

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.